TOP STORIES

• REGULATORY MHLW Group Launches Study for Post-Marketing Safety Measures to Boost Global Harmonization, Efficiency
  September 1, 2021

• REGULATORY MHLW Panel Shelves Decision on Entresto’s Hypertension Use, Clears Otsuka’s Eczema Med and More
  August 31, 2021

• REGULATORY MHLW Discussing Mandatory Reporting System for Unstable Drug Supplies
  August 30, 2021

• BUSINESS Medical Societies Issue Joint Statement in Face of Possible Stockout of Abraxane, Calling for Continued Treatment
  August 30, 2021

• BUSINESS Nippon Shinyaku Aims to Maximize Value of Viltepso, Double Sales, Operating Profits in 10 Years: President
  August 27, 2021

• BUSINESS Chugai to File Antibody Cocktail for COVID-19 Prevention among Close Contact Individuals
  August 27, 2021

• REGULATORY Japan Approves Forxiga for CKD, Rinvoq’s Atopic Dermatitis Use and More
  August 26, 2021

• BUSINESS ASKA to Accelerate Innovative Pharma Biz, Not Generics; President Sees Trivial Impact from Follow-On Blopress AG
  August 25, 2021

• REGULATORY Pharma Leaders Support Draft Industry Vision, but Stress Need for Price Maintenance of Patented Meds: Confab
  August 25, 2021

• ORGANIZATION EFPIA Japan Appoints Sanofi’s Takahiko Iwaya as New Chair
  August 25, 2021

• BUSINESS Drug Makers’ Q1 Operating Profits Eclipsing Projections on One-Time Gains, Product Growth
  August 24, 2021

• REGULATORY PAFSC to Review Astellas’ Padcev, Pfizer’s JAK Inhibitor, AZ’s Lupus Drug and More
  August 24, 2021

• REGULATORY Takeda’s 1st Cell Therapy Up for PAFSC Review on Sept. 6
  August 24, 2021

• REGULATORY New Pharma Vision to Set Out Clear Goal, KPIs after Lawmaker Calls
  August 23, 2021

• REGULATORY Sharp Drop in Suspected Violations Seen in FY2020 Drug Promotion, but Comparison Difficult due to COVID-19: MHLW
  August 23, 2021

• ORGANIZATION New Established Drugs’ Group Places Top Priority on Stable Generic Supply; Research-Driven and Foreign Firms to Join
  August 20, 2021

• BUSINESS Yamasa Ramps Up API CMO Biz for Oligonucleotides, mRNA Drugs amid Changes in Modalities
  August 19, 2021

• BUSINESS Choseido Likely to Face Administrative Penalty over Manufacturing Flaws
  August 18, 2021

• BUSINESS Japan Pharma Market Delivers 1st Growth in 5 Qtrs in April-June: IQVIA
  August 18, 2021

• REGULATORY 14 Firms Flock to Get Approval for E Keppra Generics towards December Listing
  August 17, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 61
• 62
• 63
• 64
• 65
• 66
• 67
• 68
• 69
• …
• Next ›
• 最終 »